There were 2,381 press releases posted in the last 24 hours and 440,413 in the last 365 days.

Contact

Please use this form to send email to PR contact of this press release:
AB Science fait le point sur la demande d’autorisation de mise sur le marché du masitinib dans la sclérose latérale amyotrophique auprès de l’Agence Européenne des Médicaments

TO:



FROM:

Please check your email address!

Please, do not fill this field.

Please, do not change this field.

Please, do not fill if your javascript is turned off.

captcha image